Chapter 13: Changes in 2022 WHO classification of parathyroid tumors - 26/02/25
Abstract |
The latest 2022 WHO classification of the parathyroid tumors incorporates recent data on parathyroid pathophysiology, in particular from genetic sequencing. It highlights histological features potentially indicative of underlying genetic abnormalities, because of their implications for patient management. Immunohistochemical markers can help characterize parathyroid lesions and molecular screening. This new classification is a reminder of the imperative need to provide pathologists with comprehensive clinical and paraclinical information for accurate pathological lesion characterization.
Le texte complet de cet article est disponible en PDF.Keywords : Parathyroid adenoma, Parathyroid carcinoma, Atypical parathyroid tumor, Multi-glandular parathyroid disease, Parafibromin, WHO classification
Plan
Vol 86 - N° 1
Article 101702- février 2025 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?

